Stock Moves | China Resources Pharmaceuticals Up 10% with 20% Higher Earnings Last Year

SighingCashier · 2026-03-25T02:16:01+00:00

China Resources Pharmaceuticals' profit attributable to shareholders increased 20.73% year-over-year to 4.045 billion yuan, with earnings per share of 0.64 yuan and a final dividend of 0.122 yuan per share. Revenue growth reached 4.62% to 269.574 billion yuan, with the stock price rising 9.7% to 4.88 yuan.

SighingCashier

2026-03-25 02:16:01

Abstract generation in progress

China Resources Pharmaceutical (03320) reported a 20% increase in profit last year, with the stock price rising by 10%, reaching a high of HKD 4.91.

As of 10:05 a.m., the stock was at HKD 4.88, up 9.7%, with a turnover of HKD 159 million.

The company announced that for the year ending December 2025, attributable net profit was HKD 4.045 billion, up 20.73% year-on-year; earnings per share were HKD 0.64, with a final dividend of HKD 0.122 per share.

During the period, revenue reached HKD 269.574 billion, an increase of 4.62% year-on-year. The revenue share of the three main business segments—pharmaceutical manufacturing, medical distribution, and retail pharmacy—was 16.8%, 78.7%, and 4.5%, respectively.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.